Evidence map›Paper›PMID 37766367›Full record

ArticleViruses2023

The Antiviral Factor SERINC5 Impairs the Expression of Non-Self-DNA.

Yuhang Shi, Sydney Simpson, Shahad K Ahmed, Yuexuan Chen, Aidin Tavakoli-Tameh, Sanath Kumar Janaka, David T Evans, Ruth Serra-Moreno

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. SERINC5 counters retroviruses and non-retroviruses.Frontiers in cellular and infection microbiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yuhang ShiMicrobiology and Immunology, University of Rochester Medical Center, Rochester, NY 14620, USA.ORCID 0000-0002-8533-846X
Sydney SimpsonQuidelOrtho, Rochester, NY 14626, USA.
Shahad K AhmedMicrobiology and Immunology, University of Rochester Medical Center, Rochester, NY 14620, USA.
Yuexuan ChenMicrobiology and Immunology, University of Rochester Medical Center, Rochester, NY 14620, USA.
Aidin Tavakoli-TamehPharmaceutical Product Development, Middleton, WI 53562, USA.
Sanath Kumar JanakaKelonia Therapeutics, Boston, MA 02210, USA.ORCID 0000-0003-2341-1526
David T EvansPathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI 53792, USA.ORCID 0000-0003-2498-6292
Ruth Serra-MorenoMicrobiology and Immunology, University of Rochester Medical Center, Rochester, NY 14620, USA.ORCID 0000-0002-1923-6414
University of Rochester Medical Center · USPharmaceutical Product Development (United States) · USUniversity of Wisconsin–Madison · US

Funding

KIR and MHC Class I Immunogenetics in SIV InfectionR37AI095098 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI David T Evans · 2019 to 2026
$5.6M
Tethering lentiviral restriction to Fc-mediated antibody responsesR01AI155163 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI EVANS, DAVID T · 2020 to 2024
$3.2M
NIAID NIH HHS R01 AI155163NIAID NIH HHS R37 AI095098
6 · The paper itself

Abstract

SERINC5 is a restriction factor that becomes incorporated into nascent retroviral particles, impairing their ability to infect target cells. In turn, retroviruses have evolved countermeasures against SERINC5. For instance, the primate lentiviruses (HIV and SIV) use Nef, Moloney Murine Leukemia Virus (MLV) uses GlycoGag, and Equine Infectious Anemia Virus (EIAV) uses S2 to remove SERINC5 from the plasma membrane, preventing its incorporation into progeny virions. Recent studies have shown that SERINC5 also restricts other viruses, such as Hepatitis B Virus (HBV) and Classical Swine Fever Virus (CSFV), although through a different mechanism, suggesting that SERINC5 can interfere with multiple stages of the virus life cycle. To investigate whether SERINC5 can also impact other steps of the replication cycle of HIV, the effects of SERINC5 on viral transcripts, proteins, and virus progeny size were studied. Here, we report that SERINC5 causes significant defects in HIV gene expression, which impacts virion production. While the underlying mechanism is still unknown, we found that the restriction occurs at the transcriptional level and similarly affects plasmid and non-integrated proviral DNA (ectopic or non-self-DNA). However, SERINC5 causes no defects in the expression of viral RNA, host genes, or proviral DNA that is integrated in the cellular genome. Hence, our findings reveal that SERINC5's actions in host defense extend beyond blocking virus entry.

Indexed as

Classical Swine Fever VirusHIV InfectionsAnimalsAntiviral AgentsCell MembraneDNAHorsesMiceProvirusesRetroviridaeSwineAntiviral AgentsDNAectopic DNAHIVnon-self-DNASERINC5transcriptional restriction

Identifiers

PMID37766367
PMCPMC10537789
OpenAlexW4386879446

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.